JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics

Source Summary

JPMorgan analysts believe a potential acquisition of Apogee Therapeutics (NASDAQ: APGE) by AbbVie Inc. (NYSE: ABBV) would be a strategically important move that could significantly strengthen AbbVies pharmaceutical...